Nuclear Factor Erythroid 2 Related Factor 2 and Mitochondria Form a Mutually Regulating Circuit in the Prevention and Treatment of Metabolic Syndrome
Antioxidants & Redox Signaling · 2024-10 · 41 (10-12) · 744-768
DOI: 10.1089/ars.2023.0339 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants & Redox Signaling, online erschienen am 22.10.2024. Verfasst von Jiawei Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Mitochondrial Biology and Medicine, The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Scie…. Hauptthemen laut MEDLINE: Metabolic Syndrome, Mitochondria, NF-E2-Related Factor 2, Oxidative Stress. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 249 Literaturangaben.
Abstract (Originalsprache)
Significance: Metabolic syndrome (MetS) has become a major global public health problem and there is an urgent need to elucidate its pathogenesis and find more effective targets and modalities for intervention. Recent Advances: Oxidative stress and inflammation are two of the major causes of MetS-related symptoms such as insulin resistance and obesity. Nuclear factor erythroid 2 related factor 2 (Nrf2) is one of the important systems responding to oxidative stress and inflammation. As cells undergo stress, cysteines within Kelch-like ECH-associated protein 1 (Keap1) are oxidized or electrophilically modified, allowing Nrf2 to escape ubiquitination and be translocated from the cytoplasm to the nucleus, facilitating the initiation of the antioxidant transcriptional program. Meanwhile, a growing body of evidence points out a specific modulation of mitochondrial homeostasis by Nrf2 . After nuclear translocation, Nrf2 activates downstream genes involved in various aspects of mitochondrial homeostasis, including mitochondrial biogenesis and dynamics, mitophagy, aerobic respiration, and energy metabolism. In turn, mitochondria reciprocally activate Nrf2 by releasing reactive oxygen species and regulating antioxidant enzymes. Critical Issues: In this review, we first summarize the interactions between Nrf2 and mitochondria in the modulation of oxidative stress and inflammation to ameliorate MetS, then propose that Nrf2 and mitochondria form a mutually regulating circuit critical to maintaining homeostasis during MetS. Future Directions: Targeting the Nrf2 –mitochondrial circuit may be a promising strategy to ameliorate MetS, such as obesity, diabetes, and cardiovascular diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Mitochondrial Biology and Medicine, The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an, China.
- Department of Orthopedics Trauma, Shanghai Changhai Hospital, Naval Military Medical University, Shanghai, China.
- School of Health and Life Sciences, University of Health and Rehabilitation Sciences, Qingdao, China.
ORCID-Profile: Jiankang Liu
Zitieren
APA
Zhang, J., Lv, W., Zhang, G., Zeng, M., Cao, W., Su, J., Cao, K., & Liu, J. (2024). Nuclear Factor Erythroid 2 Related Factor 2 and Mitochondria Form a Mutually Regulating Circuit in the Prevention and Treatment of Metabolic Syndrome. Antioxidants & Redox Signaling, 41(10-12), 744-768. https://doi.org/10.1089/ars.2023.0339
Vancouver
Zhang J, Lv W, Zhang G, Zeng M, Cao W, Su J, et al. Nuclear Factor Erythroid 2 Related Factor 2 and Mitochondria Form a Mutually Regulating Circuit in the Prevention and Treatment of Metabolic Syndrome. Antioxidants & Redox Signaling. 2024;41(10-12):744-768. doi:10.1089/ars.2023.0339
BibTeX
@article{Zhang2024,
author = {Zhang, Jiawei and Lv, Weiqiang and Zhang, Guanfei and Zeng, Mengqi and Cao, Wenli and Su, Jiacan and Cao, Ke and Liu, Jiankang},
title = {Nuclear Factor Erythroid 2 Related Factor 2 and Mitochondria Form a Mutually Regulating Circuit in the Prevention and Treatment of Metabolic Syndrome},
journal = {Antioxidants & Redox Signaling},
year = {2024},
volume = {41},
number = {10-12},
pages = {744--768},
doi = {10.1089/ars.2023.0339}
}
EUVIMED